Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    SEC Filing Details

    SEC Filing Details

    Document Details

    Form
    4
    Filing Date
    Jan 26, 2023
    Document Date
    Jan 24, 2023
    Form Description
    Statement of changes in beneficial ownership of securities
    Filing Group
    3,4,5
    Company
    Daré Bioscience
    Issuer
    DARE BIOSCIENCE, INC.
    Filer
    JOHNSON SABRINA MARTUCCI

    Filing Formats

    View HTML
    Download PDF
    Download DOC
    Download XLS
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top